Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | NEUROG3 |
| Upstream (Parents) |
|---|
| (<<) BMP8B → NEUROG3 |
| (<<) CASP9 → NEUROG3 |
| (<<) CENPF → NEUROG3 |
| (<<) E2F2 → NEUROG3 |
| (<<) ELF2 → NEUROG3 |
| (<<) ELF4 → NEUROG3 |
| (<<) ENO2 → NEUROG3 |
| (<<) GPX7 → NEUROG3 |
| (<<) LYPLA2 → NEUROG3 |
| (<<) MRAS → NEUROG3 |
| (<<) N4BP3 → NEUROG3 |
| (<<) PLCB4 → NEUROG3 |
| (<<) RPS6KA3 → NEUROG3 |
| (<<) TPSG1 → NEUROG3 |
| Downstream (Children) |
|---|
| NEUROG3 → EHD1 (>>) |
| NEUROG3 → EN2 (>>) |
| NEUROG3 → FHIT (>>) |
| NEUROG3 → HDAC11 (>>) |
| NEUROG3 → PLA2G12A (>>) |
